BioStock: BiBBInstruments CEO: “First order sends positive signals”

For BiBBInstruments, 2024 revolved around clinical evaluation. The company is now kicking off the new year with its first order for EndoDrill GI, from US clinic UC Davis Health. BioStock reached out to CEO Fredrik Lindblad to learn more about this commercial milestone.  

Read the interview at biostock.se:

https://www.biostock.se/en/2025/01/bibbinstruments-ceo-first-order-sends-positive-signals/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se